Showing results (321-330 of 427) with videos related to

Sort By:
Pageof 43
Hepatology (Baltimore, Md.)|December 19, 2018
Aging-Related Expression of Twinfilin-1 Regulates Cholangiocyte Biological Response to InjuryLuca Maroni, Claudio Pinto, Debora Maria Giordano, et al.
Journal of Hepatology|December 26, 2021
Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complexAmaia Navarro-Corcuera, Tejasav S Sehrawat, Nidhi Jalan-Sakrikar, et al.
Hepatology (Baltimore, Md.)|October 19, 2020
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging SystemAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- MiceCristina Di Giorgio, Ginevra Urbani, Silvia Marchianò, et al.
Science Translational Medicine|September 13, 2023
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver diseaseScott H Waddell, Yuelin Yao, Paula Olaizola, et al.
The Journal of Pathology|July 26, 2020
miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axisMoritz A Loeffler, Jun Hu, Martina Kirchner, et al.
Journal of Hepatology|September 20, 2020
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental modelsPui Y Lee-Law, Paula Olaizola, Francisco J Caballero-Camino, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Genome-wide DNA methylation markers associated with metabolic liver cancerSamuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Gastro Hep Advances|April 25, 2025
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver CancerSamuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Hepatology (Baltimore, Md.)|February 10, 2026
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytesEnara Markaide, Laura Izquierdo-Sanchez, Irene Olaizola, et al.
Pageof 43